Associated Papers
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
Perera SD et al.
Current Opinion in Lipidology, 2024
Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant.
Albers K et al.
Atherosclerosis, 2014
Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.
Mendoza-Barberá E et al.
Journal of Lipid Research, 2013
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
Surendran RP et al.
Journal of Internal Medicine, 2012
Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.
Evans D et al.
Atherosclerosis, 2011
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.
Pisciotta L et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2011
Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
Charrière S et al.
Atherosclerosis, 2009
Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Dorfmeister B et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
Select a paper to view details